Mass spectrometry analysis of the influenza virus
- 10 September 2008
- journal article
- review article
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 28 (1) , 35-49
Abstract
The role of mass spectrometry to probe characteristics of the influenza virus, and vaccine and antiviral drugs that target the virus, are reviewed. Genetic and proteomic approaches have been applied which incorporate high resolution mass spectrometry and mass mapping to genotype the virus and establish its evolution in terms of the primary structure of the surface protein antigens. A mass spectrometric immunoassay has been developed and applied to assess the structure and antigenicity of the virus in terms of the hemagglutinin antigen. The quantitation of the hemagglutinin antigen in vaccine preparations has also been conducted that is of importance to their efficacy. Finally, the characterization and quantitation of antiviral drugs against the virus, and their metabolites, have been monitored in blood, serum, and urine. The combined approaches demonstrate the strengths of modern mass spectrometric methods for the characterization of this killer virus. © 2008 Wiley Periodicals, Inc., Mass Spec Rev 28:35–49, 2009 [This article was published online 10 September 2008. An error was subsequently identified. This notice is included in the online and print versions to indicate that both have been corrected 7 November 2008.]Keywords
This publication has 60 references indexed in Scilit:
- Global Surveillance of Emerging Influenza Virus Genotypes by Mass SpectrometryPLOS ONE, 2007
- Characterization of the Capsid Protein Glycosylation of Adeno-Associated Virus Type 2 by High-Resolution Mass SpectrometryJournal of Virology, 2006
- A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometryProteomics, 2006
- Mass Spectrometric Sequencing and Acylation Character Analysis of the C-Terminal Anchoring Segment from Influenza A HemagglutininEuropean Journal of Mass Spectrometry, 2006
- Determination of serum amantadine by liquid chromatography-tandem mass spectrometryClinica Chimica Acta, 2005
- InfluenzaThe Lancet, 2003
- Characterization of intact microorganisms by MALDI mass spectrometryMass Spectrometry Reviews, 2001
- Antigenic Surveillance of the Influenza Virus by Mass SpectrometryBiochemistry, 1999
- Disarming Flu VirusesScientific American, 1999
- Rapid identification of proteins by peptide-mass fingerprintingCurrent Biology, 1993